BLI - Banque de Luxembourg Investments
Position in MRK — Merck & Co., Inc.
CIK 2052594
LUXEMBOURG CITY, N4
Position in MRK
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$10,922,500
+$4,246,405 QoQ
Shares Held
85,000
+53.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#717
of 3,769 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BLI - Banque de Luxembourg Investments holds $170,862,031 across 8 Drug Manufacturers - General names. MRK ranks #5 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
370,958 | $70,341,055 | |
| 2 | JNJ |
Johnson & Johnson
|
135,819 | $34,493,951 | |
| 3 | LLY |
ELI LILLY & Co
|
28,740 | $34,471,621 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
247,000 | $14,232,140 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
85,000 | $10,922,500 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
45,231 | $5,714,484 | |
| 7 | ABBV |
AbbVie Inc.
|
1,399 | $352,044 | |
| 8 | AMGN |
Amgen Inc
|
923 | $334,236 |
All Filings in MRK
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,922,500 | 85,000 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $6,676,095 | 55,500 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,841,930 | 55,500 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $5,875,100 | 70,000 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $6,198,228 | 78,300 | Shares | Defined | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||